Search Results

You are looking at 1 - 10 of 69 items for :

  • "HCV infection" x
Clear All

transient elastography (FibroScan) in chronic HCV infection Abstract Z. Gastroenterol. 48 611 . [43]. J. Stebbing L. Farouk G. Pano M. Anderson L. R. Jiao S. Mandalia M. Bower B. Gazzard M. Nelson 2010 A meta

Restricted access
Interventional Medicine and Applied Science
Authors: Koji Hamasaki, Susumu Eguchi, Tatsuki Ichikawa, Mitsuhisa Takatsuki, Masaaki Hidaka, Kosho Yamanouchi, Kensuke Miyazaki, Takamitsu Inokuma and Takashi Kanematsu

References 1. D.B. Amyin 2008 Prespective study of liver transplant recipients with HCV infection; evidence for a

Restricted access
Interventional Medicine and Applied Science
Authors: Enikő Sárváry, Zs. Gerlei, E. Dinya, E. Tóth, M. Varga, R. Chmel, M. Molnar, A. Remport, B. Nemes, L. Kobori, D. Görög, J. Fazakas, I. Gaal, J. Járay, F. Perner and R. Langer

(HCV) infection: relation to HCV viraemia J Egypt Public Health Assoc. 78 3–4 209 223 . 51. C

Restricted access
Hungarian Medical Journal
Authors: Nimzing G. Ladep, Oche O. Agbaji, Patricia A. Agaba, Muazu A. Mohammed, Godwin E. Imade and John A. Idoko

Objective: To determine the relationship between the immunological status and anti-HCV detection of HIV-1 infected individuals in an HIV/AIDS cohort within an African population. Design: Retrospective study of randomly selected HIV/AIDS patients. Methods: The biodata of 1044 consenting HIV infected patients were analyzed retrospectively. These patients had been enrolled following the confirmation of their HIV status by western blot assay after an initial reactive ELISA. Blood obtained from the patients were subjected to serological tests to determine their anti-HCV antibody status using third generation Enzyme Immunoassay (DIA.PRO Diagnostic, Bioprobes srl, Italy). CD4 count was done by flow cytometry (Partec Cyflow, Germany) and viral load by PCR (Roche Amplicor 1.50). The data were analyzed using the Epi Info 2004 statistical software. Results: Ninety out of 1044 patients (8.6%) were positive for anti-HCV antibodies. The rate of HCV infection was directly proportional to the CD4+ group (6.8% vs. 15.4% for < 201 and > 800, respectively, p = 0.026). Conclusion: There is an associated higher chance of detecting anti-HCV in sera of the HIV-1 infected patients whose immunological status are better compared to severely immunocompromised ones.

Restricted access

399 401 Pár, A., Kisfali, P., Melegh, B. és mtsai: Genetic polymorphisms in IL-10, IL-28B and LTA genes in HCV infection. Do they have protective role and predict

Restricted access

S. Feng 2006 Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus (HCV) infection Hepatology 44 4Suppl.1 3 . [44]. M. F. Abdelmalek R. J. Firpi C. Soldevila

Restricted access

-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus (HCV) infection [abstract]. Hepatology, 2006, 44 (Suppl. 1) , A3. Feng S. Long

Restricted access

Hezode, C., Forestier, N., Dusheiko, G. és mtsai: Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N. Engl. J. Med., 2009, 360 , 1839–1850. Dusheiko G

Restricted access

. és mtsai: Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N. Engl. J. Med., 2009, 360 , 1839–1850. Dusheiko G. Telaprevir and peginterferon with

Restricted access
Orvosi Hetilap
Authors: Mihály Makara, Gábor Horváth, Judit Gervain, Alajos Pár, Ferenc Szalay, László Telegdy, István Tornai, Eszter Újhelyi and Béla Hunyady

without ribavirin for chronic HCV infection. N. Engl. J. Med., 2009, 360 , 1839–1850. Dusheiko G. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

Open access